Sarah A Wall, MD

Sarah A Wall, MD

Physician

4.9 out of 5

Specialty:Hematology

Gender: female

Academic Title: Assistant Professor in the College of Medicine

Research Program: Cancer Control

  • About Me

    I am a hematologist who specializes in treating patients with blood cancers, such as leukemia, myelodysplastic syndromes and myelofibrosis. My area of focus is geriatrics (i.e., the effect of age on blood cancer diagnosis and treatment), as well as blood and marrow transplantation. Every patient is a person with family and friends and a life that has just been turned upside down by a diagnosis they never saw coming, and I am honored to fight alongside them and contribute to the continued growth and improvement in treatment options for their disease. At The James, we prioritize patient-centered care. This not only means identifying targets within an individual patient’s cancer cells that may be amenable to immune therapy, but it also includes our approach to each patient as a unique individual. Patients are supported by a team that includes advanced practice providers, nurses, patient care associates (PCAs), patient care resource managers (PCRMs), social workers and schedulers. I also see patients in our Cancer and Aging Resiliency (CARE) clinic, where we utilize an interdisciplinary team, including physiotherapists, audiologists, pharmacists, dieticians, nurses and case managers. This team approach affords us a more comprehensive method to patient care, with an emphasis on treating the patient rather than just the cancer itself. As a member of the Cancer Control Program at the OSUCCC – James, my research interests include pre-transplant assessment for older adults undergoing allogeneic transplant, treatment decision-making in older adults with hematologic malignancies, coordination of care with referring community providers, and the impact of aging on immune function. In addition to my clinical and research work, I am an assistant professor in the Division of Hematology at The Ohio State University College of Medicine and an active member of several organizations, including the International Society of Geriatric Oncology, the Cancer and Aging Research Group, the American Society of Hematology and the American Society of Clinical Oncology. One of the great things about working at the OSUCCC – James are the relationships that I have formed with so many experts in my own field and other complementary fields. I am constantly reminded of the quote, “If you want to go fast, go alone. If you want to go far, go together.” And it’s exactly this collaborative effort that’s at the heart of The James as we strive to create a cancer-free world.

  • Clinical Expertise

    • Myelodysplastic Syndromes
    • Graft vs Host Disease
    • Acute Myeloid Leukemias
    • Geriatrics
  • Where I See Patients

    The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

    The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

    Location Information
  • Education & Training

    Fellowship - Hematology & Oncology

    • Ohio State University Wexner Medical Center
      700 Ackerman Rd, Columbus, OH

    Residency - Hematology & Oncology

    • Ohio State University Wexner Medical Center
      700 Ackerman Rd, Columbus, OH

    Internship - Internal Medicine

    • Riverside Methodist Hospital
      3535 Olentangy River Rd, Columbus, OH

    Residency - Internal Medicine

    • Riverside Methodist Hospital
      3535 Olentangy River Rd, Columbus, OH

    Medical School

    • University of Toledo College of Medicine
      3000 Arlington Ave, Toledo, OH
  • Academic Office & Contact Information

    Academic Office:

    The James Outpatient Care 7226
    2121 Kenny Rd
    Columbus, Ohio 43221

  • Reviews

    Patient Satisfaction Review

    The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

    The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

    4.9 out of 5 overall

    Kept you informed about your condition and treatment
    4.9 / 5
    Amount of time spent with you
    4.9 / 5
    Concern for your questions and issues
    4.9 / 5
    Skill and knowledge
    4.9 / 5
    Overall quality of care
    4.9 / 5

    Patient Comments

    Reviewed on November 20, 2024

    Dr. Wall is an amazing and very empathetic doctor. I highly recommend her if you are discussing/needing stem cell/bone marrow transplant.

    Reviewed on November 20, 2024

    Dr. Wall and her staff are the best.

    Reviewed on October 30, 2024

    Dr. Wall is just outstanding. She knows everything about me & my condition and I have complete trust and faith in her expertise treating me. She is the best!

    Reviewed on August 5, 2024

    Doctor Wall always gives me her undivided attn and never feels like she is rushing even though she is very busy.

    Reviewed on May 13, 2024

    Dr. Wall spent lot of time discussing my condition and treatment

    Reviewed on March 11, 2024

    Very informative

    Reviewed on February 12, 2024

    They listen very well and very concerned about the best interest of my health

    Reviewed on February 12, 2024

    Dr Wall has always been very thorough to explain the lab findings a d to answer any questions. She always leaves me with positive thoughts. She is the best!!

    Reviewed on July 18, 2023

    My care provider Dr. Wall and her staff answered every question I had. They put me in with all the resources I need

    Reviewed on May 31, 2023

    The team kept me very well informed. And answered my questions.

  • Videos

  • Publications

    October 12, 2024

    Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies.

    Caputo J, Peddireddi A, Bhatta S, Huang Y, Bezerra E, Brammer J, Larkin K, Mims A, Vasu S, Wall S, Choe H

    Leuk Lymphoma

    September 12, 2024

    Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.

    Auletta JJ, Holter-Chakrabarty J, Munshi P, Wall S, Khera N, Knutson J, Gomez-Arteaga A, Hall AG, Foster J, Ruffin A, Robb D, Nemecek E, Rouce R, Davies SM, ACCESS Workshop Team Members

    Transplant Cell Ther

    June 12, 2024

    Impact of chronic graft-versus-host disease on non-relapse mortality and survival.

    Jiang J, Sigmund AM, Zhao Q, Elder P, Vasu S, Jaglowski S, Mims A, Choe H, Larkin K, Wall S, Grieselhuber N, William B, Penza S, Benson DM, Efebera YA, Sharma N

    Leuk Lymphoma

    June 1, 2024

    NCCN Guidelines® Insights: Systemic Mastocytosis, Version 3.2024.

    Gotlib J, Gerds AT, Abdelmessieh P, Ali H, Castells M, Dunbar A, Fein Revell R, George TI, Green S, Gundabolu K, Hexner E, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, Manchanda N, Masarova L, May J, McMahon B, Mohan SR, Nadiminti KV, Oh S, Palmer J, Patel A, Patel AA, Podoltsev N, Rein L, Salit R, Talpaz M, Wadleigh M, Wall S, Bergman MA, Hochstetler C

    J Natl Compr Canc Netw

    May 30, 2024

    Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib.

    Risch Z, Kaffenberger BH, Chung CG, Samorodnitsky E, Hoskins EL, Dao T, Smith A, Wall SA, Brammer J, Reeser JW, Wing MR, Hopkins JF, Albacker LA, Abruzzo LV, Eisele CD, Freud AG, Roychowdhury S, Walsh KE

    Haematologica

    September 23, 2023

    Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions.

    Jamy OH, Kasner M, Wall S, Ingram S, Dent D', Dudley WN, Dudley L, Scott JM, Wujcik D

    Leuk Res

    July 6, 2023

    Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.

    Jain T, Tsai HL, Elmariah H, Vachhani P, Karantanos T, Wall SA, Gondek LP, Bashey A, Keyzner A, Tamari R, Grunwald MR, Abedin S, Nadiminti KV, Iqbal M, Gerds AT, Viswabandya A, McCurdy SR, Al Malki MM, Varadhan R, Ali H, Gupta V, Jones RJ, Otoukesh S

    Haematologica

    May 1, 2023

    The Transplant Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Patients.

    Wall SA, Olin R, Bhatt V, Chhabra S, Munshi P, Hacker E, Hashmi S, Hassel H, Howard D, Jayani R, Lin R, McCurdy S, Mishra A, Murthy H, Popat U, Wood W, Rosko AE, Artz A

    Transplant Cell Ther

    November 14, 2022

    Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience.

    Jiang J, Sigmund AM, Zhao Q, Elder P, Benson DM, Vasu S, Jaglowski S, Mims A, Choe H, Larkin K, Brammer JE, Wall S, Grieselhuber N, Saad A, Penza S, Efebera YA, Sharma N

    Cancers (Basel)

    September 1, 2022

    Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

    Gerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A, George TI, Gundabolu K, Hexner E, Hobbs GS, Jain T, Jamieson C, Kaesberg PR, Kuykendall AT, Madanat Y, McMahon B, Mohan SR, Nadiminti KV, Oh S, Pardanani A, Podoltsev N, Rein L, Salit R, Stein BL, Talpaz M, Vachhani P, Wadleigh M, Wall S, Ward DC, Bergman MA, Hochstetler C

    J Natl Compr Canc Netw

    February 14, 2022

    Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium.

    Elkrief A, Hennessy C, Kuderer NM, Rubinstein SM, Wulff-Burchfield E, Rosovsky RP, Vega-Luna K, Thompson MA, Panagiotou OA, Desai A, Rivera DR, Khaki AR, Tachiki L, Lynch RC, Stratton C, Elias R, Batist G, Kasi A, Shah DP, Bakouny Z, Cabal A, Clement J, Crowell J, Dixon B, Friese CR, Fry SL, Grover P, Gulati S, Gupta S, Hwang C, Khan H, Kim SJ, Klein EJ, Labaki C, McKay RR, Nizam A, Pennell NA, Puc M, Schmidt AL, Shahrokni A, Shaya JA, Su CT, Wall S, Williams N, Wise-Draper TM, Mishra S, Grivas P, French B, Warner JL, Wildes TM, COVID-19 and Cancer Consortium

    Lancet Healthy Longev

    January 13, 2022

    Multidisciplinary Approach to Older Adults with Hematologic Malignancies-a Paradigm Shift.

    Wall SA, Stevens E, Vaughn J, Bumma N, Rosko AE, Borate U

    Curr Hematol Malig Rep

    January 1, 2022

    Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.

    Sigmund AM, Zhao Q, Jiang J, Elder P, Benson DM, Rosko A, Bumma N, Khan A, Devarakonda S, Vasu S, Jaglowski S, Mims A, Choe H, Larkin K, Brammer J, Wall S, Grieselhuber N, Saad A, Penza S, Efebera YA, Sharma N

    Front Oncol

    October 28, 2021

    Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients.

    Koenig KL, Curley TP, Mani S, Keiter A, Zhao Q, Behbehani GK, Bhatnagar B, Blachly JS, Haque TZ, Larkin KTM, Long M, Mims AS, Vasu S, Wall SA, Byrd JC, Lustberg M, Walker AR, Grieselhuber NR

    Hematol Oncol

    September 4, 2020

    Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia.

    Underwood B, Zhao Q, Walker AR, Mims AS, Vasu S, Long M, Z Haque T, Blaser BW, Grieselhuber NR, Wall SA, Behbehani GK, Blachly JS, Larkin K, Byrd JC, Garzon R, Wang TF, Bhatnagar B

    Int J Hematol Oncol

  • Consulting and Related Relationships

    At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Wall has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

    • MorphoSys
    • Cardinal Health
    • Sobi